Biogen is a biotechnology company that specializes in the discovery, development, and delivery of innovative therapies for neurological diseases. Founded in 1978, it is known for its research in conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer’s disease. The company utilizes scientific and technological advancements to create therapeutics that address unmet medical needs in the field of neuroscience. Biogen is recognized for its contributions to the life sciences and its commitment to improving patient outcomes through biopharmaceuticals.
Restructuring Within Biogen's Research Division In a strategic shift following a challenging year, Biogen’s newly appointed research leader, Jane Grogan, Ph.D., is implementing significant adjustments to the company's research team.…